Feng Xiaoru, Li Ruoqian, Yan Minqing, Yuan Changzheng, Wu You
School of Biomedical Engineering, Tsinghua Medicine, Tsinghua University, Beijing 100084, China.
School of Healthcare Management, Tsinghua Medicine, Tsinghua University, Beijing 100084, China.
Nutrients. 2025 Sep 4;17(17):2870. doi: 10.3390/nu17172870.
Liver cancer is a significant disease burden, with metabolic factors potentially influencing its risk. Diabetics, due to metabolic abnormalities, may be more sensitive to environmental exposures. Beverages like tea and alcohol could impact liver cancer risk and may influence prevention in diabetics. : This study included 30,289 diabetics and 482,292 non-diabetics aged 30-79 years from the China Kadoorie Biobank. Baseline alcohol and tea consumption during the past year was collected through questionnaires, including frequency, amount, duration, and types. Incident liver cancer cases were identified from the national health insurance system and local disease registries. Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% confidence intervals (CIs). : During a median follow-up of 9.6 years for diabetics and 10.1 years for non-diabetics, 193 (0.69 cases/1000 person-years) and 398 (0.45 cases/1000 person-years) incident liver cancer cases were documented, respectively. Weekly alcohol consumption was associated with higher liver cancer risk in both groups, stronger in diabetics (HR = 1.62; 95% CI: 1.12, 2.34) than in non-diabetics (HR = 1.20, 95% CI: 1.07, 1.35). Among diabetics, the risk was higher in some weekly alcohol consumption subgroups: high-level intake (HR = 2.21; 95% CI: 1.28, 3.80), ≥30 years (HR = 1.70; 95% CI: 1.06, 2.71), or spirit (≥50% alcohol) alcohol-specific consumption (HR = 1.91; 95% CI: 1.20, 3.04), and these associations were stronger than those in non-diabetics. For weekly tea consumption, low-level intake (HR = 0.82; 95% CI: 0.68, 0.99), <10 years (HR = 0.74; 95% CI: 0.58, 0.93), 10-29 years (HR = 0.84; 95% CI: 0.71, 0.99), and green tea-specific consumption (HR = 0.86; 95% CI: 0.75, 0.98) were associated with reduced liver cancer risk in non-diabetics. However, these associations were not significant in those with diabetes. : Weekly alcohol consumption is significantly associated with an increased risk of liver cancer, especially in diabetics, while tea consumption appears to lower risk only in non-diabetics, highlighting the need for alcohol reduction in diabetics.
肝癌是一项重大的疾病负担,代谢因素可能会影响其发病风险。糖尿病患者由于代谢异常,可能对环境暴露更为敏感。茶和酒精等饮品可能会影响肝癌风险,并可能对糖尿病患者的预防产生影响。本研究纳入了中国嘉道理生物银行中30289名年龄在30至79岁之间的糖尿病患者和482292名非糖尿病患者。通过问卷调查收集过去一年的基线酒精和茶的摄入量,包括频率、数量、持续时间和种类。从国家医疗保险系统和当地疾病登记处识别出肝癌发病病例。采用Cox比例风险回归模型估计风险比(HRs)和95%置信区间(CIs)。在糖尿病患者中位随访9.6年、非糖尿病患者中位随访10.1年期间,分别记录了193例(0.69例/1000人年)和398例(0.45例/1000人年)肝癌发病病例。两组中每周饮酒均与较高的肝癌风险相关,在糖尿病患者中更强(HR = 1.62;95% CI:1.12,2.34),高于非糖尿病患者(HR = 1.20,95% CI:1.07,1.35)。在糖尿病患者中,某些每周饮酒亚组的风险更高:高摄入量(HR = 2.21;95% CI:1.28,3.80)、≥30年(HR = 1.70;95% CI:1.06,2.71)或烈酒(酒精含量≥50%)特定饮酒量(HR = 1.91;95% CI:1.20,3.04),且这些关联比非糖尿病患者更强。对于每周饮茶,低摄入量(HR = 0.82;95% CI:0.68,0.99)、<10年(HR = 0.74;95% CI:0.58,0.93)、10 - 29年(HR = 0.84;95% CI:0.71,0.99)以及特定饮用绿茶(HR = 0.86;95% CI:0.75,0.98)与非糖尿病患者肝癌风险降低相关。然而,这些关联在糖尿病患者中并不显著。每周饮酒与肝癌风险增加显著相关,尤其是在糖尿病患者中,而饮茶似乎仅在非糖尿病患者中降低风险,这凸显了糖尿病患者需要减少饮酒。